Latest Financing News

Page 18 of 563
Latitude 66’s four exploration permits covering the KSB Project in northern Finland are now legally final after no further appeal was lodged by the deadline. The decision removes a regulatory obstacle as the company advances a project with a 650,000-ounce gold resource and a preliminary post-tax NPV8 of about US$485 million.
Maxwell Dee
Maxwell Dee
4 Nov 2026
Skyworks Solutions has begun operating as a larger RF semiconductor group after completing its Qorvo combination, targeting at least US$500 million in annual cost synergies. The deal arrives as standalone fiscal 2026 profit and cash flow declined, leaving execution and integration central to the investment case.
Victor Sage
Victor Sage
4 Nov 2026
WasteCo has completed the first $3 million stage of Navaa Holdings’ strategic investment, combining a $2.014 million share issue with an unsecured term loan. A further $6.074 million subscription could give the Singapore investor 50.01% of WasteCo, subject to due diligence and shareholder approval.
Maxwell Dee
Maxwell Dee
4 Nov 2026
Revvity has lifted its full-year 2026 outlook after reporting stronger third-quarter revenue, organic growth and profitability. The life sciences and diagnostics group is also preparing to sell its China immunodiagnostics business for up to US$200 million.
Ada Torres
Ada Torres
4 Nov 2026
Waters delivered a stronger-than-expected third quarter, lifting every component of its 2026 guidance while organic growth accelerated across instruments, consumables and reagents. The company also acquired MOBILion Systems to extend its mass spectrometry technology into proteomics.
Sophie Babbage
Sophie Babbage
4 Nov 2026
Sysco delivered modest underlying growth in fiscal Q1 2027 and kept its adjusted EPS and local volume targets intact, while shifting full-year sales expectations to the lower end of its existing range. The quarter also brought a permanent CFO appointment as the company prepares for the proposed Jetro Restaurant Depot acquisition.
Victor Sage
Victor Sage
4 Nov 2026
Pfizer has lifted its 2026 revenue and adjusted earnings guidance after a quarter in which newer and acquired medicines grew strongly enough to offset steep declines in COVID-19 products. Overall revenue was flat, while reported net income fell 8%.
Victor Sage
Victor Sage
4 Nov 2026
Burgundy Diamond Mines says its Ekati diamond mine has ceased operations after a funding process failed to secure a transaction capable of keeping the mine open. Its subsidiaries tied to Ekati and the Naujaat project have entered receivership, leaving the board to assess the company’s remaining options.
Maxwell Dee
Maxwell Dee
3 Nov 2026
Viking Mines is advancing its Linka tungsten project in Nevada across drilling, metallurgy, processing, permitting and growth workstreams, but the proposed restart remains pre-resource and pre-feasibility. Pending assays, bulk-sample testing and US permitting will determine whether the fast-to-market strategy can become a mine development case.
Maxwell Dee
Maxwell Dee
3 Nov 2026
Centaurus Metals has completed the first A$17.8 million share placement to Glencore, marking the first cash injection from a proposed US$40 million strategic funding package for its Jaguar Nickel Project in Brazil. The next milestones are CNGR’s initial share issue, shareholder approval and a Final Investment Decision.
Maxwell Dee
Maxwell Dee
3 Nov 2026
QMines has raised more than targeted through a $5.5 million placement, giving its Mt Chalmers copper-gold development a larger funding base as drilling continues. The company also intends to seek a further $1 million from eligible shareholders, although both the SPP and deferred sale proceeds remain subject to completion.
Maxwell Dee
Maxwell Dee
3 Nov 2026
Osmond Resources has secured A$3.75 million from a share placement to advance its Orión project in Spain, taking pro forma cash above A$6.5 million. The raise strengthens the company’s near-term funding position, but remains modest against the approximately US$300 million required by its preliminary development study.
Maxwell Dee
Maxwell Dee
3 Nov 2026

Browse the archive

Full archive